Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
80 participants
INTERVENTIONAL
2009-12-31
2013-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
This study evaluates the efficacy of compression stockings (23-32 mmHg) in the treatment SVT of the legs. The investigators hypothesis is that compression treatment is superior to no compression in alleviating disease related clinical symptoms.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Compression Aided Management of Edema in Patients With C3 Venous Disease
NCT00766974
A Comparison of the Effects of Neuromuscular Electrical Stimulation and Intermittent Pneumatic Compression on Blood Flow in the Lower Limb
NCT01894997
Compression Therapy Versus Surgery in the Treatment of Superficial Venous Reflux
NCT01701661
Effects of External Leg Compression Devices on Healing and Blood Clotting
NCT03050671
INvestigating SIGnificant Health TrendS in the Management of Superficial Vein Thrombosis
NCT02699151
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
no compression
no compression stockings worn during a 3 weeks period
no compression
no compression stockings worn during the study
compression stockings
compression stockings class II (23-32 mm Hg) worn during the day for up to 3 weeks
compression
compression stockings class II (23-32 mm Hg) worn during the day for up to 3 weeks
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
no compression
no compression stockings worn during the study
compression
compression stockings class II (23-32 mm Hg) worn during the day for up to 3 weeks
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* thrombus extent of at least 5 cm confirmed by duplex sonography,
* clinical signs of inflammation (pain, erythema)
Exclusion Criteria
* concomitant deep vein thrombosis,
* thrombophilia,
* active malignoma,
* immobility,
* peripheral arterial occlusive disease,
* superficial vein thrombosis after sclerotherapy
* incision and clot expression
* excessive leg configuration not covered by ready made compression stockings
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Medical University of Vienna
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Kornelia Boehler
MD
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Kornelia Böhler, MD
Role: PRINCIPAL_INVESTIGATOR
Medical University of Vienna, Department of General Dermatology
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
EKNr 772/2009
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.